BBOT
BridgeBio Oncology Therapeutics Inc.

45
Loading...
Loading...
Bridgebio Oncology Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Ka malignancies. The company was founded on August 1, 2016 and is headquartered in South San Francisco, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

What is Market Cap of BridgeBio Oncology Therapeutics Inc.?
What is the 52-week high for BridgeBio Oncology Therapeutics Inc.?
What is the 52-week low for BridgeBio Oncology Therapeutics Inc.?
What is BridgeBio Oncology Therapeutics Inc. stock price today?
What was BridgeBio Oncology Therapeutics Inc. stock price yesterday?
What is the PE ratio of BridgeBio Oncology Therapeutics Inc.?
What is the Price-to-Book ratio of BridgeBio Oncology Therapeutics Inc.?
What is the 50-day moving average of BridgeBio Oncology Therapeutics Inc.?

Latest BBOT News

View
No BBOT news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.